Initiation of Antiretroviral Therapy Containing Integrase Inhibitors Increases the Risk of IRIS Requiring Hospitalization

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e23-e26. doi: 10.1097/QAI.0000000000001397.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Adult
  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • Female
  • France
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Integrase Inhibitors / administration & dosage
  • HIV Integrase Inhibitors / adverse effects*
  • Hospitalization
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / chemically induced*
  • Immune Reconstitution Inflammatory Syndrome / immunology
  • Immunocompromised Host
  • Incidence
  • Male
  • Middle Aged
  • Patient Selection
  • Prospective Studies
  • Risk Assessment
  • Risk Factors

Substances

  • HIV Integrase Inhibitors